The True Cost of Focusing on Cost Instead of Cost-Effectiveness
When payors consider only the cost of the medication and not the cost and risk to the patient, doctor, and healthcare system, the irony is that not only is this terrible for patient health, it can be more costly in the end.
Patient Group Sues AMA, Says the Org Shouldn’t Be Charging for CPT Codes
PatientRightsAdvocate.org sued the American Medical Association this week, arguing the trade group has no valid copyright over the CPT codes that providers must use to bill for care. It follows a public letter Senator Bill Cassidy sent to the AMA last year accusing it of "abus[ing] [its] government-backed monopoly by charging exorbitant fees to anyone using the CPT code set."
Aligned Marketplace Secures $20M for Advanced Primary Care Marketplace
Venrock led Aligned Marketplace's Series A round. In total, the company has raised $31 million to date.
Bristol Myers Squibb Protein Degrader Wins First-in-Class FDA Nod in Multiple Myeloma
Bristol Myers Squibb’s Zenbexus is the first FDA-approved drug in a new class of cancer drugs called CELMoDs. The pharma company is positioning this molecule as a successor to its legacy products for multiple myeloma.
Healthcare Keeps Buying AI. But Nobody’s Building the Workforce to Run It.
Most younger professionals entering the workforce have little visibility into interoperability, digital health infrastructure, or healthcare data architecture as career pathways.